COMMUNIQUÉS West-GlobeNewswire

Axovant Announces Financial Results and Corporate Updates for Fourth Quarter and Fiscal Year Ended March 31, 2019
11/06/2019
Established diversified pipeline of three clinical-stage gene therapy programs for serious neurological disorders including Parkinson’s disease, GM1 gangliosidosis, and Tay-Sachs SUNRISE-PD Phase 2 trial of AXO-Lenti-PD [...]
Oral semaglutide demonstrated cardiovascular safety in people with type 2 diabetes and established cardiovascular disease or high cardiovascular risk in PIONEER 6 trial
11/06/2019
San Francisco, US, 11 June 2019 - Novo Nordisk today announced that the PIONEER 6 trial achieved its primary endpoint by demonstrating non-inferiority of major adverse cardiovascular events (MACE) with oral semaglutide [...]
Vital® Partners With Baptist Health to Deliver Complete Vitrea® Enterprise Imaging Solution
11/06/2019
MINNETONKA, Minn., June 11, 2019 (GLOBE NEWSWIRE) -- Vital announced today continued success with Baptist Health in the implementation of the Vitrea Enterprise Imaging solution. Baptist Health is Arkansas’ largest [...]
La société XBiotech ajoutée à l'indice Russell 3000®
11/06/2019
AUSTIN, Texas, 11 juin 2019 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ : XBIT) a annoncé aujourd'hui que la société avait été ajoutée à la liste préliminaire de l'indice boursier élargi Russell 3000 ® qui prendra effet [...]
Cerecor Set to Join Russell 3000® Index
11/06/2019
ROCKVILLE, Md., June 11, 2019 (GLOBE NEWSWIRE) -- Cerecor Inc. (NASDAQ: CERC), a biopharmaceutical company focused on becoming a leader in development and commercialization of treatments for rare and orphan diseases in [...]
DEINOVE & AVRIL completing the development of a natural feed additive
11/06/2019
The tests aimed at validating the dosage required have confirmed a very good efficacy of the ingredient The teams are working to develop a formulation that meets regulatory and industrial requirements for bringing a [...]
Ossur Hf : Transactions in relation to share buyback program
11/06/2019
Announcement no. 36/2019 11 June 2019 Transactions in relation to share buyback program On 14 May 2019, Össur hf. initiated a share buy-back program, see Company announcement no. 31/2019. The purpose of the share [...]
VALNEVA fera un point sur l’avancée de ses programmes de vaccins Lyme et chikungunya le 9 juillet à New York lors d’une journée investisseurs consacrée à la R&D
11/06/2019
Valneva fera un point sur l’avancée de ses programmes de vaccins Lyme et chikungunya le 9 juillet à New York lors d’une journée investisseurs consacrée à la R&D Conférence retransmise en direct à partir de 8.30am [...]
Valneva to Present Lyme Disease and Chikungunya Vaccine Updates at R&D Investor Day in New York City on July 9th
11/06/2019
Valneva to Present Lyme Disease and Chikungunya Vaccine Updates at R&D Investor Day in New York City on July 9 th Live webcast beginning at 8:30am EDT / 2:30pm CEST Saint Herblain (France), June 11, 2019 – Valneva [...]
Eurobio Scientific and Vivo Medical Group enter into exclusive negotiations for the acquisition of two companies in the United Kingdom
11/06/2019
Eurobio Scientific and Vivo Medical Group enter into exclusive negotiations for the acquisition of two companies in the United Kingdom Paris, June 11, 2019 – 5:45 pm Eurobio Scientific enters into exclusive negotiations [...]
Eurobio Scientific et Vivo Medical Group entrent en négociation exclusive pour l’acquisition de deux sociétés au Royaume-Uni
11/06/2019
Eurobio Scientific et Vivo Medical Group entrent en négociation exclusive pour l’acquisition de deux sociétés au Royaume-Uni Paris, le 11 juin 2019 – 17h45 Eurobio Scientific (FR0013240934, ALERS, éligible PEA-PME), [...]
Inventiva Announces End of Patient Recruitment for its Phase IIa Trial in the Treatment of MPS VI
11/06/2019
Inventiva Announces End of Patient Recruitment for its Phase IIa Trial in the Treatment of MPS VI Last patient enrolled in the Phase IIa iMProveS trial evaluating odiparcil in MPS VI patients 20 patients included in the [...]
Inventiva annonce la fin du recrutement des patients pour son étude de Phase IIa dans le traitement de la MPS VI
11/06/2019
Inventiva annonce la fin du recrutement des patients pour son étude de Phase IIa dans le traitement de la MPS VI Dernier patient recruté dans l’étude de Phase IIa iMProveS évaluant odiparcil chez des patients atteints [...]
Dermatologists Share Skin Care Tips for People With Vitiligo
11/06/2019
June is Vitiligo Awareness Month ROSEMONT, Ill., June 11, 2019 (GLOBE NEWSWIRE) -- Millions of people worldwide have vitiligo, a condition that causes the skin to lose its natural color, resulting in patches of light [...]
Transactions under Novozymes’ stock buyback program
11/06/2019
Please read the full announcement in the attached PDF Attachment 2019_17_Stock_Buybackprogram_EN
UPDATE - BioNovelus, Inc. Announces Acquisition of Bayberry Acquisition Corp., Hires Mark Fuller as New President and Chief Executive Officer
11/06/2019
SCOTTSDALE, Ariz., June 11, 2019 (GLOBE NEWSWIRE) -- BioNovelus, Inc. (ONOV: OTC) announces that it has closed its acquisition of Bayberry Acquisition Corp. and hired Mark Fuller as its new President and CEO. Mr. Fuller [...]
Segra Expands Plant Tissue Culture Operations into U.S. Hemp Market, Leases Oregon Production Facility
11/06/2019
VANCOUVER, British Columbia, June 11, 2019 (GLOBE NEWSWIRE) -- Segra International Corp. (“ Segra ” or the “ Company ”), an agriculture technology company, is pleased to announce that it will soon begin operations in [...]
Information regarding the mandatory redemption of shares
11/06/2019
Attached: The prospectus of the mandatory takeover bid of Joint Stock Company „GRINDEKS” in English. The place and time for reading the prospectus: Law firm PricewaterhouseCoopers Legal, at 21–21 Kr.Valdemara iela, Riga [...]
Merit Medical Awarded Interventional Fluid Management Agreement With Premier
11/06/2019
SOUTH JORDAN, Utah, June 11, 2019 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic [...]

Pages